These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26065993)

  • 21. Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6.
    Jansen F; Stumpf T; Proebsting S; Franklin BS; Wenzel D; Pfeifer P; Flender A; Schmitz T; Yang X; Fleischmann BK; Nickenig G; Werner N
    J Mol Cell Cardiol; 2017 Mar; 104():43-52. PubMed ID: 28143713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sirt1 inhibited oxidized low-density lipoprotein induced smooth muscle cells inflammatory response].
    Yang R; Zhu X; Duan ZJ; Li YY; Wang YP; Yang K
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(21):1659-1663. PubMed ID: 28606256
    [No Abstract]   [Full Text] [Related]  

  • 23. Peripheral artery disease: a micro-RNA-related condition?
    Vogiatzi G; Oikonomou E; Deftereos S; Siasos G; Tousoulis D
    Curr Opin Pharmacol; 2018 Apr; 39():105-112. PubMed ID: 29679926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous Increases in Proliferation and Apoptosis of Vascular Smooth Muscle Cells Accelerate Diabetic Mouse Venous Atherosclerosis.
    Ping S; Li Y; Liu S; Zhang Z; Wang J; Zhou Y; Liu K; Huang J; Chen D; Wang J; Li C
    PLoS One; 2015; 10(10):e0141375. PubMed ID: 26488175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities.
    Wang M; Li W; Chang GQ; Ye CS; Ou JS; Li XX; Liu Y; Cheang TY; Huang XL; Wang SM
    Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):2044-53. PubMed ID: 21817107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional Long Non-coding RNAs in Vascular Smooth Muscle Cells.
    Leung A; Stapleton K; Natarajan R
    Curr Top Microbiol Immunol; 2016; 394():127-41. PubMed ID: 25910717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-125b is involved in atherosclerosis obliterans in vitro by targeting podocalyxin.
    Li X; Yao N; Zhang J; Liu Z
    Mol Med Rep; 2015 Jul; 12(1):561-8. PubMed ID: 25738314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to letter regarding article, "ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity".
    Liu R; Jin Y; Tang W; Qin L; Zhang X; Tellides G; Hwa J; Yu J; Martin KA
    Circulation; 2014 Aug; 130(8):e72. PubMed ID: 25135133
    [No Abstract]   [Full Text] [Related]  

  • 29. Epigenetic regulation of vascular smooth muscle cell function in atherosclerosis.
    Findeisen HM; Kahles FK; Bruemmer D
    Curr Atheroscler Rep; 2013 Apr; 15(4):319. PubMed ID: 23423526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs in atherosclerosis.
    Chen KC; Juo SH
    Kaohsiung J Med Sci; 2012 Dec; 28(12):631-40. PubMed ID: 23217354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs in angiogenesis and vascular smooth muscle cell function.
    Daubman S
    Circ Res; 2010 Feb; 106(3):423-5. PubMed ID: 20167936
    [No Abstract]   [Full Text] [Related]  

  • 32. LncRNA UCA1 sponges miR-26a to regulate the migration and proliferation of vascular smooth muscle cells.
    Tian S; Yuan Y; Li Z; Gao M; Lu Y; Gao H
    Gene; 2018 Oct; 673():159-166. PubMed ID: 29908280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of vascular nitric oxide pathway on vascular smooth muscle cell proliferation.
    Chen L; Dong N; Huang J; Zhu Z; Wang M; Wu K
    Int J Cardiol; 2011 Aug; 150(3):370-2. PubMed ID: 21664705
    [No Abstract]   [Full Text] [Related]  

  • 34. Cadherin:catenin complex: a novel regulator of vascular smooth muscle cell behaviour.
    George SJ; Beeching CA
    Atherosclerosis; 2006 Sep; 188(1):1-11. PubMed ID: 16438974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-155 in the pathogenesis of atherosclerosis: a conflicting role?
    Ma X; Ma C; Zheng X
    Heart Lung Circ; 2013 Oct; 22(10):811-8. PubMed ID: 23827206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic switching of vascular smooth muscle cells in the 'normal region' of aorta from atherosclerosis patients is regulated by miR-145.
    Zhang YN; Xie BD; Sun L; Chen W; Jiang SL; Liu W; Bian F; Tian H; Li RK
    J Cell Mol Med; 2016 Jun; 20(6):1049-61. PubMed ID: 26992033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. microRNA let-7g suppresses PDGF-induced conversion of vascular smooth muscle cell into the synthetic phenotype.
    Wang TM; Chen KC; Hsu PY; Lin HF; Wang YS; Chen CY; Liao YC; Juo SH
    J Cell Mol Med; 2017 Dec; 21(12):3592-3601. PubMed ID: 28699690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The roles of autophagy in vascular smooth muscle cells.
    Tai S; Hu XQ; Peng DQ; Zhou SH; Zheng XL
    Int J Cardiol; 2016 May; 211():1-6. PubMed ID: 26954728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purinergic regulation of vascular tone and remodelling.
    Burnstock G
    Auton Autacoid Pharmacol; 2009 Jul; 29(3):63-72. PubMed ID: 19566746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-362-3p inhibits the proliferation and migration of vascular smooth muscle cells in atherosclerosis by targeting ADAMTS1.
    Li M; Liu Q; Lei J; Wang X; Chen X; Ding Y
    Biochem Biophys Res Commun; 2017 Nov; 493(1):270-276. PubMed ID: 28890348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.